Increased levels of MCHR1 in SSc fibroblasts can promote PDGF-BB signaling, increase TGFβ1 and CTGF levels, modulate intracellular cAMP production, and increase the fibrotic response. Here, TGFB1 is linked to systemic sclerosis.